全文获取类型
收费全文 | 1827篇 |
免费 | 97篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 53篇 |
儿科学 | 12篇 |
妇产科学 | 37篇 |
基础医学 | 251篇 |
口腔科学 | 24篇 |
临床医学 | 92篇 |
内科学 | 599篇 |
皮肤病学 | 4篇 |
神经病学 | 121篇 |
特种医学 | 98篇 |
外科学 | 333篇 |
综合类 | 7篇 |
一般理论 | 1篇 |
预防医学 | 33篇 |
眼科学 | 9篇 |
药学 | 70篇 |
中国医学 | 1篇 |
肿瘤学 | 190篇 |
出版年
2023年 | 12篇 |
2022年 | 27篇 |
2021年 | 66篇 |
2020年 | 21篇 |
2019年 | 34篇 |
2018年 | 58篇 |
2017年 | 33篇 |
2016年 | 59篇 |
2015年 | 49篇 |
2014年 | 64篇 |
2013年 | 78篇 |
2012年 | 128篇 |
2011年 | 152篇 |
2010年 | 75篇 |
2009年 | 62篇 |
2008年 | 124篇 |
2007年 | 116篇 |
2006年 | 119篇 |
2005年 | 122篇 |
2004年 | 119篇 |
2003年 | 93篇 |
2002年 | 96篇 |
2001年 | 28篇 |
2000年 | 28篇 |
1999年 | 19篇 |
1998年 | 17篇 |
1997年 | 21篇 |
1996年 | 14篇 |
1995年 | 16篇 |
1994年 | 10篇 |
1993年 | 11篇 |
1992年 | 4篇 |
1991年 | 6篇 |
1990年 | 4篇 |
1989年 | 5篇 |
1988年 | 2篇 |
1987年 | 9篇 |
1986年 | 7篇 |
1985年 | 4篇 |
1984年 | 3篇 |
1983年 | 3篇 |
1982年 | 5篇 |
1981年 | 2篇 |
1980年 | 3篇 |
1979年 | 1篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1971年 | 1篇 |
1970年 | 2篇 |
1969年 | 1篇 |
排序方式: 共有1935条查询结果,搜索用时 20 毫秒
31.
32.
Effect of statin on restenosis after radius stent implantation in patients with acute coronary syndrome 总被引:2,自引:0,他引:2
Nishikawa H Miura S Shimomura H Kawamura A Tsujita K Shirai K Matsuo K Arai H Saku K 《Journal of atherosclerosis and thrombosis》2005,12(6):302-306
Despite reports that statin treatment reduces the rate of coronary restenosis with a balloon expandable stent, there is no evidence that statins affect the incidence of restenosis with a self-expanding Radius stent. Ninety-five patients with acute coronary syndrome who had been implanted with a Radius stent were classified into two groups: those with hyperlipidemia and initial statin treatment (statin group, n = 38) and those without statin treatment (comparative group, n = 57). At six months after stent implantation, the rate of coronary restenosis was significantly lower in the statin group (10.5%) than control group (28.1%) (p = 0.033), while there were no differences in morphology, maximal inflation pressure or stent size between the two groups. Interestingly, there was no difference in the serum lipid profile between the two groups at the 6-month follow-up, although the statin group had a significantly lower rate of restenosis. In conclusion, initial statin therapy reduced the rate of coronary restenosis even when a Radius stent was implanted. 相似文献
33.
Ricardo Petraco Rasha Al-Lamee Matthias Gotberg Andrew Sharp Farrel Hellig Sukhjinder S. Nijjer Mauro Echavarria-Pinto Tim P. van de Hoef Sayan Sen Nobuhiro Tanaka Eric Van Belle Waldemar Bojara Kunihiro Sakoda Martin Mates Ciro Indolfi Salvatore De Rosa Christian J. Vrints Steven Haine Hiroyoshi Yokoi Flavio L. Ribichini Martjin Meuwissen Hitoshi Matsuo Luc Janssens Ueno Katsumi Carlo Di Mario Javier Escaned Jan Piek Justin E. Davies 《American heart journal》2014
34.
35.
Rei Isshiki Shuzo Kobayashi Masao Iwagami Daimu Tsutumi Yasuhiro Mochida Kunihiro Ishioka Machiko Oka Kyoko Maesato Hidekazu Moriya Takayasu Ohtake Sumi Hidaka 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2014,18(3):291-296
Cognitive impairment has long been recognized as a complication of chronic kidney disease. However, there is little information available regarding regional cerebral blood flow (rCBF) in patients with peritoneal dialysis (PD). Therefore, we evaluated rCBF using brain single photon emission computed tomography (SPECT). We conducted a cross‐sectional study in our hospital. Eighteen consecutive PD patients who could visit the hospital by themselves without any history of stroke were examined by Technetium‐99 m‐labeled ethylcrysteinate dimer brain SPECT. An easy Z‐score imaging system (eZIS) was used to compare rCBF in PD patients with those in age‐matched healthy controls. We also evaluated cognitive dysfunction with the mini‐mental state examination (MMSE) questionnaire. Only one patient showed an MMSE score of 18 points, and the remaining 14 patients were considered as normal (MMSE ≥ 27), and three patients were considered to have mild cognitive impairment (24 ≤ MMSE ≤ 26). In all patients, rCBF in the posterior cingulated gyri, precunei, and parietal cortices was significantly decreased. The ratio of the reduction of rCBF in each region relative to that of rCBF across the whole brain correlated positively with the PD duration (r = 0.559; P < 0.05). The serum β2‐microglobulin level was significantly higher in patients who had a higher ratio of rCBF reduction compared with those with lower ratios. In conclusion, all PD patients in the present study had decreased rCBF irrespective of MMSE scores. 相似文献
36.
37.
Hermida J Lopez FL Montes R Matsushita K Astor BC Alonso A 《The American journal of cardiology》2012,109(1):95-99
High-sensitivity C-reactive protein (hs-CRP) is a marker for the risk of cardiovascular and overall mortality. However, information about the association between hs-CRP and mortality in patients with atrial fibrillation is scarce. A total of 293 participants of the Atherosclerosis Risk In Communities study with a history of AF and hs-CRP levels available were studied. During a median follow-up of 9.4 years, 134 participants died (46%). The hazard ratio of all-cause mortality associated with the highest versus the lowest tertile of hs-CRP was 2.52 (95% confidence interval 1.49 to 4.25) after adjusting for age, gender, history of cardiovascular diseases, and cardiovascular risk factors. A similar trend was observed for cardiovascular mortality (57 events; hazard ratio 1.90, 95% confidence interval 0.81 to 4.45). The Congestive heart failure, Hypertension, Age >75 years, Diabetes, and previous Stroke or transient ischemic attack (CHADS2) score was also associated with all-cause and cardiovascular mortality, with an adjusted hazard ratio of 3.39 (95% confidence interval 1.91 to 6.01) and 8.71 (95% confidence interval 2.98 to 25.47), respectively, comparing those with a CHADS2 score >2 versus a CHADS2 score of 0. Adding hs-CRP to a predictive model including the CHADS2 score was associated with an improvement of the C-statistic for total mortality (from 0.627 to 0.677) and for cardiovascular mortality (from 0.700 to 0.718). In conclusion, high levels of hs-CRP constitute an independent marker for the risk of mortality in patients with atrial fibrillation. 相似文献
38.
39.
Ichinose K Origuchi T Kawashiri SY Iwamoto N Fujikawa K Aramaki T Kamachi M Arima K Tamai M Nakamura H Ida H Kawakami A Eguchi K 《Rheumatology international》2012,32(2):483-487
We present six cases of patients with Japanese rheumatoid arthritis (RA) treated with a tumor necrosis factor (TNF)-alpha blocking agent, adalimumab as monotherapy for 220?weeks. All six patients were women, and the median age was 54.0?±?7.07?years old. The median duration of the disease was 7.43?±?11.1?years, and the median disease activity score (DAS28-CRP) was 5.35?±?0.69. Three of six patients were able to continue to receive this treatment for 220?weeks successfully, and the DAS28-CRP decreased to 1.89?±?0.75. Two patients withdrew because of lack of efficacy, and one patient withdrew because of adverse events (non-Hodgkin lymphoma). Adalimumab resulted in a sustained clinical response in RA patients during 220-week follow-up. 相似文献
40.
Ohba K Noh JY Unno T Satoh T Iwahara K Matsushita A Sasaki S Oki Y Nakamura H 《Endocrine journal》2012,59(8):663-667
The syndrome of inappropriate secretion of thyrotropin (SITSH) is defined as the inappropriate non-suppression of serum TSH in the presence of elevated free thyroid hormone; TSH-secreting pituitary adenomas and the syndrome of resistance to thyroid hormone are the main etiologies of SITSH. In addition, erroneous thyroid function testing may result in the diagnosis of this syndrome. A 63-year-old woman was referred because of suspected SITSH. Laboratory tests showed a normal TSH (0.52 μIU/L; normal range: 0.5-5.0) measured by sandwich Elecsys, and elevated FT4 (3.8 ng/dL; normal range: 0.9-1.6) and FT3 (7.6 pg/mL; normal range: 2.3-4.0), determined by competitive Elecsys. To exclude possible assay interference, aliquots of the original samples were retested using a different method (ADVIA Centaur), which showed normal FT4 and FT3 levels. Eight hormone levels, other than thyroid function tests measured by competitive or sandwich Elecsys, were higher or lower than levels determined by an alternative analysis. Subsequent examinations, including gel filtration chromatography, suggested interference by substances against ruthenium, which reduced the excitation of ruthenium, and resulted in erroneous results. The frequency of similar cases, where the FT4 was higher than 3.2 ng/dL, in spite of a non-suppressed TSH, was examined; none of 10 such subjects appeared to have method-specific interference. Here, a patient with anti-ruthenium interference, whose initial thyroid function tests were consistent with SITSH, is presented. This type of interference should be considered when thyroid function is measured using the Elecsys technique, although the frequency of such findings is likely very low. 相似文献